1. Ocrelizumab in a case of refractory chronic inflammatory demyelinating polyneuropathy with anti‐rituximab antibodies. (8th November 2020) Authors: Casertano, S.; Signoriello, E.; Rossi, F.; Di Pietro, A.; Tuccillo, F.; Bonavita, S.; Lus, G. Journal: European journal of neurology Issue: Volume 27:Number 12(2020) Page Start: 2673 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗